The pandemic of the century that challenged every field of human achievements and contrivances till today is getting into our hold with the draconic endeavors of the competent world. COVID-19 made lakhs of lives grind to a halt, where we saw both gage and helplessness at the initial stages of it’s betiding. There was no dissent between developed or underdeveloped nations in the epidemic circumstances, where we met the complexity in generating vaccines as per the DNA structures of the microbe.
The experimental procedures are on a fast pace throughout the world while the medical field is still struggling to keep their oath of service. Meanwhile, more than one COVID-19 Vaccines are on the last stages of its trials in humans, showing the peak effectiveness with less side effects. The Pfizer/BioNTech PFE BNTX vaccine is on the way of trials and has been developed in 10 months. Moderna Inc. MRNA is developing a mRNA vaccine claiming 94.5% effectiveness. AstraZeneca PLC with AZN Oxford University is developing one vector based vaccine.
The challenges of storage and distribution of COVID-19 Vaccines.
Pfizer BioNTech Inc vaccine is based on a new technology that uses mRNA to activate the immune system against the virus but this vaccine needed to be kept at -70°c (-94°F) or below. This may be the first COVID-19 vaccine which gets authorization to distribute within a short time. The challenge of its distribution from the centers in the US, Germany, Belgium to hospitals around the globe is something complex as this medicine is to be kept at such lower temperatures, which is indeed a tough process. It can be stored either in, Dry Ice or temperature controlled refrigeration units. The Ultra-cold freezers with temperature control to -70°c to -80°c is financially challenging and for most of the hospitals and rural Healthcare centers around the world, Vaccine storage and distribution is not possible due to its sensitiveness to ultra-cold temperatures. Most of the hospitals can refrigerate only around -2°c to -8°c.
Dry Ice – An effective storage to Ultra-cold temperatures.
Once the COVID-19 vaccine has passed the testing phase, it will have to be distributed worldwide. To avoid degradation of the unstable molecules in the COVID-19 vaccine, the COVID-19 vaccine is best stored at freezing temperatures of -18°C to -80°C. These temperatures must sometimes be maintained for days. Dry ice, which has a temperature of -80°C, is the best choice for storing and transporting the COVID-19 vaccine worldwide. Dry Ice is solid carbon dioxide used in many fields, commercial and industrial and even in medicine. It has lower temperature than water made ice and leaves no residues. Dry Ice sublimes at -78.5°c at normal atmospheric pressure which makes it an effective coolant. Dry Ice required only adequate ventilation to not the pressure build up inside the packaging. Frozen vaccine in Dry Ice violent can be transported via air and land at its lowest temperatures up-to 10 days and can be stored for 6 months without any spoilage. Dry Ice has the financial advantage over refrigeration units, which requires very complex storage requirements.
Eco Green Dry Ice Build-up and Supply Services.
Eco Green Dry Ice Service, the leading high density Dry Ice manufacturers and suppliers in Dubai and Abu Dhabi, functions internationally for any service with base Dry Ice or its bulk distribution and supply in long term basis. We have a wide range of pelletizers and dry ice machines that can produce blocks of dry ice in various dimensions. We offer Dry ice for sale in UAE in large quantities or short, at risk-free environments, even for COVID-19 vaccine storage for the benefit of humanity.
The COVID-19 vaccine will undoubtedly present new challenges and we can assist you in the distribution of the COVID-19 vaccine.
Contact us today or for bulk deliveries of dry ice, or reach us: +9712 5557085
